AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SAN DIEGO -- Women who received ropivacaine as the analgesic agent in a walking epidural had fewer first-stage cesarean deliveries than those who received bupivacaine, Dr. David Campbell said at the annual meeting of the Society for Obstetric Anesthesia and Perinatology.
First-stage cesareans occurred in 9.6% of the ropivacaine group, compared with 16.5% in the bupivacaine group in this randomized study, which was designed to compare the effects of the two analgesic medications.
The incidence of spontaneous vaginal deliveries was similar between groups, said Dr. Campbell of the University of Saskatchewan, Saskatoon. Of 285 women who received ropivacaine, 50.5% had spontaneous vaginal deliveries, compared with 45.9% of the 286 who received bupivacaine.
There were no significant differences seen in the percentage of second-stage cesareans or instrumental vaginal deliveries between the two groups.
Women in both groups were also statistically similar in terms of the amount of analgesia provided and their ability to walk after the epidural was administered to them. ...
Source: HighBeam Research, Ropivacaine Linked to Fewer First-Stage Cesareans.